Tuesday, April 22, 2008

Wyeth Goes for Bargain Price on Replacement for Effexor

After Wyeth’s Pristiq long, rocky road to approval, the company’s trying to smooth the antidepressant’s path to doctors’ prescription pads with a cut-rate price. Wyeth Headquarters (Mike Derer/Associated Press) The company said during its earnings call this morning that it will price the antidepressant at a 20% discount to its older blockbuster antidepressant, Effexor XR. Pristiq is [...]

No comments: